Andlauer Healthcare Group Inc.
AND.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.22% | 4.44% | -1.73% | -9.42% | -6.59% |
| Total Depreciation and Amortization | 2.29% | -2.27% | 1.52% | 8.51% | 3.00% |
| Total Amortization of Deferred Charges | -65.11% | 322.40% | 273.55% | 274.55% | 62.19% |
| Total Other Non-Cash Items | -408.27% | -53.80% | 169.47% | 5.40% | -104.09% |
| Change in Net Operating Assets | -10.35% | 35.80% | 169.88% | 121.29% | -547.06% |
| Cash from Operations | -12.62% | 5.32% | 41.94% | 36.51% | -31.67% |
| Capital Expenditure | 51.42% | 25.03% | 69.86% | -53.65% | 30.94% |
| Sale of Property, Plant, and Equipment | -94.77% | 159.00% | -24.90% | -26.20% | -28.45% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -42.37% | -274.98% | 52.94% | 35.06% | -34.08% |
| Cash from Investing | 39.08% | 19.57% | 73.28% | -50.84% | 27.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -17.18% | 43.66% | -10.12% | -0.18% | 3.31% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 87.61% | -95.70% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -12.45% | -12.95% | -15.65% | -23.63% | -26.90% |
| Other Financing Activities | 2,650.00% | -97.14% | -441.56% | 422.22% | -90.59% |
| Cash from Financing | 46.18% | 23.67% | -484.06% | -66.52% | -149.31% |
| Foreign Exchange rate Adjustments | 260.13% | -132.13% | 122.65% | 2,547.50% | 5.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 151.06% | 70.84% | -372.83% | -1.12% | -156.19% |
